Skip to main content
. 2015 Nov 1;1(4):FSO33. doi: 10.4155/fso.15.33

Figure 1. .

Figure 1. 

Response to regorafenib of a PDGFRA mutated GIST. Response to regorafenib in a patient with liver metastasis (A, B, C) before treatment; (D, E, F) response maintained 18 months after treatment onset) from a PDGFRA exon 18 mutated gastrointestinal stromal tumor.